RNA
Closed
Avidity Biosciences inc
28.46
+0.06 (+0.21%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 28.4
Day's Range: 27.705 - 29.46
Send
sign up or login to leave a comment!
When Written:
15.35
Avidity Biosciences Inc is a biotechnology company that focuses on developing therapies based on its proprietary AOC (Antibody Oligonucleotide Conjugate) platform. The AOC platform combines the specificity of antibodies with the precision of oligonucleotide-based therapeutics to create targeted therapies for a range of diseases, including cancer, autoimmune disorders, and rare genetic diseases. Avidity's lead program is focused on developing therapies for myotonic dystrophy type 1 (DM1), a rare genetic disease that affects muscle function. The company was founded in 2012 and is headquartered in La Jolla, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








